45 related articles for article (PubMed ID: 23150505)
1. Case Report: A combination of chimeric
Li J; Zhang F; Xu M; Qiu H; Zhou C; Li L; Qin L
Front Endocrinol (Lausanne); 2023; 14():1216767. PubMed ID: 38027139
[TBL] [Abstract][Full Text] [Related]
2. Computational analysis of functional single nucleotide polymorphisms associated with the CYP11B2 gene.
Jia M; Yang B; Li Z; Shen H; Song X; Gu W
PLoS One; 2014; 9(8):e104311. PubMed ID: 25102047
[TBL] [Abstract][Full Text] [Related]
3.
Liu G; Duan Y
Front Neurosci; 2022; 16():1030551. PubMed ID: 36532271
[TBL] [Abstract][Full Text] [Related]
4. GRAde: a long-read sequencing approach to efficiently identifying the CYP11B1/CYP11B2 chimeric form in patients with glucocorticoid-remediable aldosteronism.
Wu YC; Chen CI; Chen PY; Kuo CH; Hung YH; Peng KY; Wu VC; Tsai-Wu JJ; Hsu CL;
BMC Bioinformatics; 2022 Jan; 22(Suppl 10):613. PubMed ID: 35012455
[TBL] [Abstract][Full Text] [Related]
5. A genome-wide association study identifies a novel candidate locus at the DLGAP1 gene with susceptibility to resistant hypertension in the Japanese population.
Takahashi Y; Yamazaki K; Kamatani Y; Kubo M; Matsuda K; Asai S
Sci Rep; 2021 Sep; 11(1):19497. PubMed ID: 34593835
[TBL] [Abstract][Full Text] [Related]
6. Effects of intron conversion in the human
Mopidevi B; Sivankutty I; Hao S; Ferreri NR; Kumar A
J Biol Chem; 2020 Aug; 295(32):11068-11081. PubMed ID: 32540969
[TBL] [Abstract][Full Text] [Related]
7. Posaconazole Serum Drug Levels Associated With Pseudohyperaldosteronism.
Nguyen MH; Davis MR; Wittenberg R; Mchardy I; Baddley JW; Young BY; Odermatt A; Thompson GR
Clin Infect Dis; 2020 Jun; 70(12):2593-2598. PubMed ID: 31403165
[TBL] [Abstract][Full Text] [Related]
8. Genomewide analysis of homeobox gene family in apple (
Li R; Ge H; Dai Y; Yuan L; Liu X; Sun Q; Wang X
J Genet; 2019 Mar; 98():. PubMed ID: 30945664
[TBL] [Abstract][Full Text] [Related]
9. Association of mononucleotide polymorphisms of angiotensinogen gene at promoter region with antihypertensive response to angiotensin receptor blockers in hypertensive Chinese.
Gong HT; Mu LY; Zhang T; Xu XY; Du FH
J Renin Angiotensin Aldosterone Syst; 2019; 20(1):1470320319827205. PubMed ID: 30798697
[TBL] [Abstract][Full Text] [Related]
10. Insights on the phenotypic heterogenity of 11β-hydroxylase deficiency: clinical and genetic studies in two novel families.
Valadares LP; Pfeilsticker ACV; de Brito Sousa SM; Cardoso SC; de Moraes OL; Gonçalves de Castro LC; de Oliveira RS; Lofrano-Porto A
Endocrine; 2018 Nov; 62(2):326-332. PubMed ID: 30242600
[TBL] [Abstract][Full Text] [Related]
11. A novel haplotype of low-frequency variants in the aldosterone synthase gene among northern Han Chinese with essential hypertension.
Zhang H; Li X; Zhou L; Zhang K; Zhang Q; Li J; Wang N; Jin M; Wu N; Cong M; Qiu C
Medicine (Baltimore); 2017 Sep; 96(39):e8150. PubMed ID: 28953657
[TBL] [Abstract][Full Text] [Related]
12. ACTH and Polymorphisms at Steroidogenic Loci as Determinants of Aldosterone Secretion and Blood Pressure.
MacKenzie SM; Freel EM; Connell JM; Fraser R; Davies E
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28272372
[TBL] [Abstract][Full Text] [Related]
13. Association between the CYP11 family and six cancer types.
Fan Z; Wang Z; Chen W; Cao Z; Li Y
Oncol Lett; 2016 Jul; 12(1):35-40. PubMed ID: 27347096
[TBL] [Abstract][Full Text] [Related]
14. Aldosterone Synthase Promoter Polymorphism and Cardiovascular Phenotypes in a Large, Multiethnic Population-Based Study.
Byrd JB; Auchus RJ; White PC
J Investig Med; 2015 Oct; 63(7):862-6. PubMed ID: 26200036
[TBL] [Abstract][Full Text] [Related]
15. Genetics of resistant hypertension: a novel pharmacogenomics phenotype.
El Rouby N; Cooper-DeHoff RM
Curr Hypertens Rep; 2015 Sep; 17(9):583. PubMed ID: 26198781
[TBL] [Abstract][Full Text] [Related]
16. Common polymorphisms in the CYP11B1 and CYP11B2 genes: evidence for a digenic influence on hypertension.
Alvarez-Madrazo S; Mackenzie SM; Davies E; Fraser R; Lee WK; Brown M; Caulfield MJ; Dominiczak AF; Farrall M; Lathrop M; Hedner T; Melander O; Munroe PB; Samani N; Stewart PM; Wahlstrand B; Webster J; Palmer CN; Padmanabhan S; Connell JM
Hypertension; 2013 Jan; 61(1):232-9. PubMed ID: 23150505
[TBL] [Abstract][Full Text] [Related]
17. Genetic variation at the locus encompassing 11-beta hydroxylase and aldosterone synthase accounts for heritability in cortisol precursor (11-deoxycortisol) urinary metabolite excretion.
Keavney B; Mayosi B; Gaukrodger N; Imrie H; Baker M; Fraser R; Ingram M; Watkins H; Farrall M; Davies E; Connell J
J Clin Endocrinol Metab; 2005 Feb; 90(2):1072-7. PubMed ID: 15522937
[TBL] [Abstract][Full Text] [Related]
18. Polymorphic variation in the 11beta-hydroxylase gene associates with reduced 11-hydroxylase efficiency.
Barr M; MacKenzie SM; Friel EC; Holloway CD; Wilkinson DM; Brain NJ; Ingram MC; Fraser R; Brown M; Samani NJ; Caulfield M; Munroe PB; Farrall M; Webster J; Clayton D; Dominiczak AF; Connell JM; Davies E
Hypertension; 2007 Jan; 49(1):113-9. PubMed ID: 17075029
[TBL] [Abstract][Full Text] [Related]
19. CYP11B2-CYP11B1 haplotypes associated with decreased 11 beta-hydroxylase activity.
Ganapathipillai S; Laval G; Hoffmann IS; Castejon AM; Nicod J; Dick B; Frey FJ; Frey BM; Cubeddu LX; Ferrari P
J Clin Endocrinol Metab; 2005 Feb; 90(2):1220-5. PubMed ID: 15507509
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
